Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. J&J nabs its 1st Chinese device maker
Health care giant Johnson & Johnson (NYSE:JNJ) made its 1st acquisition in China this week, picking up Guangzhou Bioseal Biotech for an undisclosed amount.
2. Kensey Nash agrees to $360M buyout by Royal DSM
Kensey Nash (NSDQ:KNSY) agreed to a $38.50-per-share cash buyout offer from Royal DSM worth about $360 million, a 33% premium over KNSY’s $29.01 closing price yesterday.
1. An upside to the European PIP breast implant scandal?
Far from scaring patients away from breast enhancement, the scandal over substandard silicone in French breast implants preceded a spike in European sales for at least one U.S. company.
